Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Cardioselective beta blocker use in patients with chronic kidney disease: a National Population-Based Study
- In: Short Communications E1 on Monday, 22 May 2017, 13:30-15:00
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: WU, Ping-Hsun (Kaohsiung Medical University Hospital, Division of Nephrology, Departement of Internal Medicine, Kaohsiung, China Taiwan)
- Co-author(s): Ping-Hsun Wu: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
Yi-Ting Lin: Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
Ming-Yen Lin: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
Hui-Min Hsieh: Department of Public Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan, Province of China
Feng-Shiuan Jian: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
Shang-Jhy Hwang: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
Yi-Huang Kang: Department of Information Management, National Sun Yat-sen University, Kaohsiung, Taiwan, Province of China - Abstract:
Backgrounds
β-blockers use is associated with improved cardiovascular outcomes in patients with cardiovascular disease. However, limited data focus on patients with chronic kidney disease (CKD). Besides, previous studies focused on the survival outcome and used a non-active comparison, prevalent-user design.
Aims
We investigated the effect of
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023